Clinical data | Total IgAN group (n = 79) | Control group (n = 50) | P | IgAN CKD 1–2 (n = 62) | IgAN CKD 3–5 (n = 17) | P |
---|---|---|---|---|---|---|
Man/woman (n/%) | 50/29 (63/37) | 31/19 (62/38) | NS | 37/25 (60/40) | 13/4 (76/24) | NS |
Age (year) | 46.3 ± 11.2 | 45.8 ± 12.8 | NS | 43.8 ± 11.2 | 55.5 ± 7.7 | < 0.001 |
Average systolic/diastolic RR (Hgmm) | 122/73 ± 14/9 | 127/76 ± 13/9 | 0.04 | 120/72 ± 11/8 | 129/76 ± 16/9 | 0.014 |
24 h pulse pressure (Hgmm) | 49.2 ± 10.7 | 51.2 ± 9.3 | NS | 48.3 ± 12.8 | 53.7 ± 7.7 | 0.048 |
Diurnal index systolic (%) | 10.67 ± 5.6 | 9.1 ± 5.5 | NS | 11.7 ± 6.2 | 7.2 ± 5.2 | 0.004 |
Metabolic parameters | ||||||
Hypertension (n, %) | 60 (76) | 31 (62) | 0.045 | 43 (69) | 17 (100) | 0.004 |
BMI (kg/m2) | 28.1 ± 4.8 | 27.9 ± 5.1 | NS | 26 ± 4.7 | 28.4 ± 4.5 | 0.015 |
Dyslipidaemia (n, %) | 36 (46) | 26 (52) | NS | 26 (42) | 10 (59) | NS |
Diabetes (n, %) | 25 (32) | 17 (34) | NS | 17 (27) | 8 (47) | NS |
eGFR (ml/min) | 87.2 ± 32.4 | 107.4 ± 18.3 | < 0.001 | 98.2 ± 27.8 | 39.7 ± 29.6 | < 0.001 |
Duration of kidney disease (year) | 10.8 ± 9.4 | - | - | 10 ± 9 | 11.5 ± 10 | NS |
Smoking (n, %) | 14 (18) | 10 (20) | NS | 10 (16) | 4 (23) | NS |
Metabolic syndrome (n, %) | 22 (28) | 15 (30) | NS | 14 (22) | 8 (47) | 0.023 |
ASCVD risk score (%) | 6.49 | 7.37 | NS | 4.63 | 7.10 | NS |
Arterial stiffness parameters | ||||||
Stiffness index (SI, m/s) | 10.3 ± 2.59 | 8.88 ± 2.2 | < 0.001 | 9.99 ± 2.13 | 10.97 ± 2.29 | 0.045 |
Pulse wave velocity (PWVao, m/s) | 9.89 ± 1.65 | 8.6 ± 1.5 | < 0.001 | 9.71 ± 1.61 | 10.72 ± 1.61 | 0.029 |
Aortic systolic blood pressure (SBPao, Hgmm) | 121.1 ± 18.3 | 122.0 ± 19.3 | NS | 119.5 ± 16.4 | 127.9 ± 23.9 | NS |
Augmentation index (Aix) | -20.3 ± 29.0 | -30.4 ± 28.2 | 0.049 | -21.9 ± 29.9 | -13.4 ± 23.6 | NS |
Echocardiographic parameters | ||||||
LVEF (%) | 62.4 ± 6.5 | 63.4 ± 6.9 | NS | 62.2 ± 4.9 | 63.1 ± 7.7 | NS |
LVMI | 106.6 ± 22.8 | 108.67 ± 21.1 | NS | 101.5 ± 16 | 125.2 ± 23 | < 0.001 |
LVM (g) | 204.4 ± 51.4 | 200.5 ± 49.1 | NS | 194.9 ± 44.0 | 239.0 ± 48.8 | < 0.001 |
LVEDD (cm) | 4.95 ± 0.4 | 4.83 ± 0.4 | NS | 4.93 ± 0.39 | 5.05 ± 0.41 | NS |
DD (n/%) | 37 (47) | 20 (40) | NS | 24 (39) | 13 (76) | 0.003 |
E/A | 1.05 ± 0.33 | 1.07 ± 0.38 | NS | 1.11 ± 0.32 | 0.85 ± 0.24 | < 0.001 |
EDT (ms) | 192 ± 40.6 | 186.7 ± 40.4 | NS | 185.8 ± 33.8 | 215.3 ± 43.5 | 0.003 |
Ea (cm/s) | 13.2 ± 3.69 | 13.3 ± 5.0 | NS | 14.0 ± 2.13 | 10.5 ± 2.08 | < 0.001 |
Aa (cm/s) | 11.3 ± 3.0 | 11.1 ± 3.0 | NS | 11.0 ± 3.41 | 12.3 ± 2.63 | NS |
Ea/Aa | 1.28 ± 0.57 | 1.32 ± 0.69 | NS | 1.38 ± 0.54 | 0.91 ± 0.32 | < 0.001 |
E/Ea | 4.88 ± 1.31 | 4.08 ± 1.54 | NS | 4.72 ± 0.95 | 5.43 ± 1.40 | 0.024 |
LVR | 0.94 ± 0.25 | 1.04 ± 0.33 | NS | 0.94 ± 0.24 | 0.97 ± 0.26 | 0.035 |
Laboratory results | ||||||
Hb (g/dl) | 13.6 ± 1.53 | 13.8 ± 1.42 | NS | 13.8 ± 1.56 | 13.1 ± 1.54 | NS |
MAU (mg/day) | 484.6 ± 658.4 | 35.9 ± 30.9 | < 0.001 | 420.8 ± 550.9 | 717.3 ± 721.8 | 0.016 |
HUS (umol/l) | 320.5 ± 76.7 | 315.4 ± 65.8 | NS | 307.9.4 ± 76.7 | 366.8 ± 68.8 | 0.015 |
Total cholesterol (mmol/l) | 5.03 ± 1.21 | 4.95 ± 1.20 | NS | 5.05 ± 0.95 | 5.16 ± 1.41 | NS |
HDL cholesterol (mmol/l) | 1.28 ± 0.51 | 1.25 ± 0.45 | NS | 1.32 ± 0.64 | 1.15 ± 0.36 | NS |
TG (mmol/l) | 1.69 ± 1.05 | 1.86 ± 1.10 | NS | 1.60 ± 0.90 | 2.00 ± 1.12 | NS |
Therapy | ||||||
ACEI/ARB (n, %) | 65 (82) | 27 (54) | 0.003 | 45 (72) | 14 (82) | NS |
BB (n, %) | 22 (28) | 19 (38) | NS | 10 (16) | 3 (18) | NS |
Statin (n, %) | 26 (33) | 21 (42) | NS | 12 (19) | 4 (23) | NS |
CCB (n, %) | 22 (28) | 17 (34) | NS | 12 (19) | 4 (23) | NS |